LONDON - Shortwave Life Sciences Plc (AQSE: PSY), a company focused on developing innovative therapies for mental health care, has announced its unaudited interim results for the six months ending on ...
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback